CClinicalTrials.gg
CompletedNCT02748538Updated May 16, 2018

The Posturing After Retinal Detachment (Post RD) Trial

An observational study in Retinal Detachment, sponsored by Moorfields Eye Hospital NHS Foundation Trust. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-16.

Sponsored by Moorfields Eye Hospital NHS Foundation Trust · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
262
Ages
18 Years and older
Sex
All
01

Study summary

A randomised controlled trial to evaluate the effect of face-down posturing on retinal displacement and distortion following retinal detachment repair.

Read the detailed description

During the surgical repair of a retina detachment, a gas bubble is inserted into the eye to keep the retina flat. Following this, it is common to ask patients to adopt a certain head position for a set period of time after their operation. This is known as posturing. It is thought that by adopting a certain head position/posturing, the bubble aids re-attachment of the retina. However, when the retinal detachment involves the macula (central portion of the retina) it has been shown that the retina can shift (or displace) post-operatively, leading to distortion in the patient's vision.

The purpose of this study is to investigate whether adopting different head positions following surgery for macula involving retinal detachments, can reduce retinal displacement and visual distortion. The investigators plan to recruit 368 patients. Patients will be in follow up for a period of six months. The study will be operational at two different hospitals in the United Kingdom.

02

Conditions studied

  • Retinal Detachment
03

In context

Retinal Detachment

207 studies on the registry are indexed under Retinal Detachment; 27 are open to participants now.

This study's enrollment of 262 is above the median of 64 across 60 observational studies indexed under Retinal Detachment.

Browse Retinal Detachment studies →

Lead sponsor

Moorfields Eye Hospital NHS Foundation Trust is the lead sponsor of 48 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients presenting with macula-involving rhegmatogenous retinal detachment

Inclusion criteria

  • Fovea-involving rhegmatogenous retinal detachment
  • History of central visual loss within the past 14 days
  • Patients undergoing vitrectomy and gas surgery, under local anaesthetic
  • Able to give informed consent
  • 18 years old and over

Exclusion criteria

Exclusion Criteria:

  • Previous vitrectomy or cryo-buckle surgery
  • Retinal detachment surgery requiring silicone oil tamponade
  • Existing ophthalmic condition which limits the patient's visual acuity (BCVA 6/36 or worse)
  • Inability to posture post-operatively or commit to follow-up visits
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
262 participants (actual)
Patient registry
No

Groups and cohorts

  • Face Down

    To posture in the face down position for the first 24 hours following surgery.

  • Position to Support the Break

    The head is positioned so that the retinal breaks (which caused the retinal detachment) are positioned at the highest point of the eye and well supported by the intra-ocular gas bubble left within the eye at the completion of surgery.

06

What researchers measure

Primary outcomes

  1. To assess the proportion of patients in each treatment group with retinal displacement at 26 weeks after surgery

    The proportion of patients in each treatment group with retinal displacement at 26 weeks after surgery

    Time frame: 26 Weeks

Secondary outcomes

  1. To assess the degree of retinal displacement on autofluorescence imaging

    Degree of retinal displacement on autofluorescence imaging at 26 weeks

    Time frame: 26 Weeks

  2. To assess proportion of patients in each group with retinal displacement at 8 weeks

    The proportion of patients in each group with retinal displacement at 8 weeks after surgery.

    Time frame: Eight weeks

  3. To report the mean (SD)/median (IQR) ETDRS visual acuity score at two different time-points

    To report the mean (SD)/median (IQR) ETDRS visual acuity score at 8 and 26 weeks after surgery in each treatment group

    Time frame: Eight and 26 weeks

  4. To report the mean(SD)/median(IQR) Objective distortion score at two different time-points

    To report the mean(SD)/median(IQR) Objective distortion score at 8 and 26 weeks after surgery in each treatment group - with Objective distortion measured with D Charts

    Time frame: Eight and 26 weeks

  5. To report the mean (SD) / median (IQR) Visual function score as measured using the Visual Function Questionnaire

    To report the mean (SD) / median (IQR) Visual function score as measured using the Visual Function Questionnaire (NEI Visual Function Questionnaire 25) in each treatment group at 26 weeks after surgery.

    Time frame: 26 Weeks

Other outcomes

  1. To assess subjective distortion by comparing patient's scores from the distortion questionnaire

    Subjective distortion: a comparison of patient's scores in the distortion questionnaire at 8 \& 26 weeks.

    Time frame: Eight and 26 weeks

  2. To assess the persistence of post-operative distortion: paired comparisons of subjective & objective distortion at two separate time-points

    Persistence of post-operative distortion: paired comparisons of subjective \& objective distortion at 8 and 26 weeks.

    Time frame: Eight and 26 weeks

  3. To assess the correlation between retinal displacement and distortion

    Correlation between retinal displacement and distortion: the correlation between the incidence retinal displacement on autofluorescence imaging and distortion (questionnaire and D chart assessments) at 8 or 26 weeks.

    Time frame: Eight or 26 weeks

  4. To assess the relationship of exploratory outcome parameters at 26 weeks to self-recorded posturing diary

    Relationship of exploratory outcome parameters at 26 weeks to self-recorded posturing diary

    Time frame: 26 Weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Casswell EJ, Yorston D, Lee E, Heeren TFC, Harris N, Zvobgo TM, Tarafdar S, Xing W, Bourmpaki E, Bunce C, Keane P, Charteris DG. Effect of Face-Down Positioning vs Support-the-Break Positioning After Macula-Involving Retinal Detachment Repair: The PostRD Randomized Clinical Trial. JAMA Ophthalmol. 2020 Jun 1;138(6):634-642. doi: 10.1001/jamaophthalmol.2020.0997. PubMed 32297923 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02748538
Lead sponsor
Moorfields Eye Hospital NHS Foundation Trust
Responsible party
Sponsor
First posted
Apr 22, 2016
Start date
May 17, 2016
Primary completion
May 1, 2018
Completion
May 1, 2018
Last update
May 16, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion